🩺 Joint pain

## Overview Joint pain — medically termed **arthralgia** (ICD-10: M25.5) — refers to discomfort, aching, or soreness arising from any joint in the body, including the surrounding ligaments, tendons, cartilage, and bone. It is one of the most common musculoskeletal complaints worldwide, affecting an estimated 15–25 % of the adult population at any given time. A 2014 global burden-of-disease analysis found that hip and knee osteoarthritis alone affected over 240 million people, making it a leading cause of disability (PMID:24553908). Joint pain may be **acute** (lasting days to weeks, often after injury or infection) or **chronic** (persisting three months or longer, as in osteoarthritis or rheumatoid arthritis). It can involve a single joint (monoarticular), a few joints (oligoarticular), or many joints (polyarticular). The pattern, timing, and associated symptoms are crucial clues for diagnosis. People search for information about joint pain because it directly impairs daily activities — walking, climbing stairs, gripping objects, or sleeping. Understanding when joint pain is self-limiting versus when it signals a serious condition can prevent complications and guide timely treatment. --- ## Common Causes Joint pain has diverse etiologies. The following are ranked roughly by frequency in the general adult population. ### 1. Osteoarthritis (OA) The most common cause of chronic joint pain, OA results from progressive degradation of articular cartilage, subchondral bone remodeling, and low-grade synovial inflammation. Mechanical stress, aging, obesity, and genetic predisposition are primary risk factors. Weight-bearing joints (knees, hips) and the hands are most commonly affected. Pain is typically worse with activity and improves with rest. ### 2. Soft-Tissue and Overuse Injuries Tendinitis, bursitis, ligament sprains, and repetitive strain injuries frequently present as periarticular pain that patients describe as "joint pain." Mechanisms include microtrauma from repetitive motion, acute mechanical overload, or deconditioning. Common examples include rotator cuff tendinitis, lateral epicondylitis ("tennis elbow"), and trochanteric bursitis. ### 3. Rheumatoid Arthritis (RA) An autoimmune disorder in which the immune system attacks the synovial membrane, causing chronic inflammation, joint erosion, and systemic symptoms. RA typically presents with symmetric polyarthritis of the small joints (hands, wrists, feet), morning stiffness lasting more than 30 minutes, and fatigue. Prevalence is approximately 0.5–1 % of the adult population (PMID:20872595). ### 4. Gout and Crystal Arthropathies Gout results from deposition of monosodium urate crystals in joints, most classically the first metatarsophalangeal joint (big toe). Calcium pyrophosphate deposition disease (CPPD, or "pseudogout") similarly involves crystal-driven inflammation but more often affects the knees and wrists. Attacks are typically sudden, severely painful, and accompanied by redness and swelling. ### 5. Post-Viral Arthralgia Many viral infections — including influenza, parvovirus B19, hepatitis B and C, chikungunya, and SARS-CoV-2 — can trigger widespread joint pain. The mechanism involves immune complex deposition, direct synovial infection, or cytokine-mediated inflammation. Pain is usually self-limiting but may persist for weeks to months. ### 6. Post-Traumatic Joint Pain Fractures extending into the joint surface, meniscal tears, ligamentous injuries (e.g., ACL tears), and dislocations cause acute joint pain through direct structural damage and secondary inflammation. ### 7. Other Autoimmune and Inflammatory Conditions Psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), reactive arthritis, and other spondyloarthropathies can present with joint pain as a prominent feature. ### 8. Septic Arthritis Bacterial infection of a joint (most commonly *Staphylococcus aureus*) is a medical emergency. It typically presents as acute monoarticular pain with warmth, swelling, erythema, fever, and an inability to move the joint. ### 9. Fibromyalgia and Central Sensitization Widespread musculoskeletal pain, including diffuse joint pain, accompanied by fatigue, sleep disturbance, and cognitive difficulties. The mechanism involves altered central pain processing rather than structural joint damage. --- ## RED FLAGS Seek **immediate medical attention** (emergency department or call emergency services) if joint pain is accompanied by any of the following: - **Hot, red, severely swollen joint with fever** — may indicate septic arthritis, a joint infection requiring emergency aspiration and intravenous antibiotics - **Sudden inability to bear weight or move the joint** after trauma — suggests fracture, dislocation, or significant ligament rupture - **Joint pain with a rapidly spreading skin rash, high fever, and rigors** — raises concern for systemic infection, including meningococcemia or endocarditis - **Joint pain with chest pain, shortness of breath, or jaw pain** — in rare cases, shoulder or arm pain may be a referred symptom of cardiac ischemia - **Joint deformity visible after an injury** — suggests dislocation or displaced fracture - **Joint pain with petechiae or purpura** — may indicate vasculitis or a hematologic emergency - **New joint swelling in an immunocompromised patient** (e.g., on chemotherapy, organ transplant, or HIV) — higher risk of septic arthritis or opportunistic infection - **Joint pain in a child with fever and refusal to move the limb** — must rule out septic arthritis or osteomyelitis, which can cause permanent joint damage if untreated --- ## Self-Care at Home For mild-to-moderate joint pain without red-flag features, several evidence-based non-pharmacological strategies may provide relief. ### Physical Activity and Exercise Low-impact exercise is one of the most effective interventions for chronic joint pain. A Cochrane review found that land-based therapeutic exercise reduces pain and improves physical function in knee osteoarthritis (PMID:25461849). Recommended activities include: - **Walking** — 30 minutes most days, at a comfortable pace - **Swimming or water aerobics** — buoyancy reduces joint loading - **Cycling** — low impact on weight-bearing joints - **Tai chi and yoga** — improve flexibility, balance, and pain perception - **Strengthening exercises** — particularly quadriceps and hip abductor muscles for knee OA ### Weight Management Every kilogram of body weight lost reduces the load on the knee joint by approximately 4 kilograms during walking. Weight loss of ≥ 5 % of body weight has been associated with clinically meaningful improvements in pain and function in overweight patients with knee OA. ### Hot and Cold Therapy - **Ice packs** (15–20 minutes, with a cloth barrier) may reduce swelling and numb acute pain - **Warm compresses or warm baths** can ease stiffness and improve blood flow in chronic conditions ### Rest and Joint Protection - Avoid activities that provoke sharp or worsening pain - Use assistive devices (walking stick, ergonomic tools) to offload affected joints - Supportive footwear with cushioned insoles may reduce impact on knee and hip joints ### Topical Therapies - **Topical NSAIDs** (e.g., diclofenac gel) deliver local anti-inflammatory effects with lower systemic absorption - **Capsaicin cream** (0.025–0.075 %) may modestly reduce pain through substance P depletion; requires consistent application for 1–2 weeks before benefit ### Mind-Body Approaches Cognitive behavioral therapy, mindfulness-based stress reduction, and relaxation techniques have demonstrated modest benefits for chronic pain management, particularly when combined with physical rehabilitation. --- ## OTC Medications That Help Over-the-counter (OTC) analgesics and anti-inflammatory agents are first-line pharmacological options for mild-to-moderate joint pain. A network meta-analysis in *The Lancet* demonstrated that NSAIDs, particularly at higher doses, are generally more effective than acetaminophen for osteoarthritis pain (PMID:28699595). | Class | Example | Typical Adult Dose | Notes | |---|---|---|---| | **Acetaminophen (paracetamol)** | Tylenol | 500–1000 mg every 6–8 hours; max 3000 mg/day (some guidelines allow 4000 mg/day in healthy adults) | First-line for mild pain; avoid in liver disease or heavy alcohol use; does not reduce inflammation | | **Oral NSAIDs** | Ibuprofen (Advil, Motrin) | 200–400 mg every 4–6 hours; max 1200 mg/day OTC | Anti-inflammatory and analgesic; take with food; avoid in renal impairment, active GI bleeding, cardiovascular disease, or third trimester of pregnancy | | **Oral NSAIDs** | Naproxen (Aleve) | 220 mg every 8–12 hours; max 660 mg/day OTC | Longer duration of action; same contraindications as ibuprofen; may carry slightly lower cardiovascular risk than some other NSAIDs | | **Topical NSAIDs** | Diclofenac gel 1 % (Voltaren) | Apply 4 g to affected joint 4 times daily (hands) or 2 times daily (knees) | Lower systemic exposure; preferred in elderly or those at GI risk; avoid on broken skin | | **Topical analgesics** | Menthol/methyl salicylate creams (Bengay, Icy Hot) | Apply to affected area up to 3–4 times daily | Counterirritant mechanism; temporary relief; avoid with oral NSAIDs if salicylate-based | | **Supplements (limited evidence)** | Glucosamine sulfate / Chondroitin | Glucosamine 1500 mg/day; Chondroitin 800–1200 mg/day | Mixed evidence; some studies suggest modest benefit in knee OA; generally well tolerated; may take 8–12 weeks for effect | **Important:** NSAIDs should generally be used at the lowest effective dose for the shortest duration needed. Patients with a history of peptic ulcer disease, chronic kidney disease, heart failure, or anticoagulant therapy should consult a clinician before use. --- ## Prescription Options When OTC measures and self-care are insufficient, prescription medications may be warranted. The 2019 ACR/Arthritis Foundation guidelines and the OARSI guidelines provide evidence-based frameworks for pharmacological management (PMID:31908163; PMID:31278997). | Class | Examples | Indication | Notes | |---|---|---|---| | **Prescription-strength NSAIDs** | Meloxicam 7.5–15 mg/day; Celecoxib 100–200 mg/day | Moderate-to-severe OA, inflammatory arthritis | Celecoxib (COX-2 selective) may have lower GI risk; cardiovascular risk remains; prescriber monitors renal and GI status | | **Corticosteroids (oral, short-course)** | Prednisone 5–20 mg/day tapering | RA flares, gout flares, crystal arthropathies | Short courses only; long-term use carries risks of osteoporosis, hyperglycemia, adrenal suppression, weight gain | | **Intra-articular corticosteroid injections** | Triamcinolone acetonide 40 mg; Methylprednisolone acetate 40–80 mg | OA (knee, hip, shoulder), inflammatory arthritis flares | Generally limited to 3–4 injections per joint per year; provides weeks to months of relief; performed by GP, rheumatologist, or orthopedist | | **DMARDs (conventional)** | Methotrexate 7.5–25 mg/week; Hydroxychloroquine 200–400 mg/day; Sulfasalazine 1–3 g/day | RA, psoriatic arthritis, SLE | Disease-modifying; do not just treat pain — they slow joint damage; require regular blood monitoring; prescribed by rheumatologist (PMID:26545940) | | **Biologic DMARDs** | Adalimumab (Humira), Etanercept (Enbrel), Tocilizumab (Actemra) | Moderate-to-severe RA, psoriatic arthritis, ankylosing spondylitis unresponsive to conventional DMARDs | Target specific immune pathways (TNF-α, IL-6, etc.); administered by injection or infusion; increased infection risk; prescribed by rheumatologist | | **Targeted synthetic DMARDs** | Tofacitinib (Xeljanz), Baricitinib (Olumiant) | RA unresponsive to other therapies | JAK inhibitors; oral administration; FDA boxed warnings regarding cardiovascular events, malignancy, and thrombosis in certain populations | | **Colchicine** | Colchicine 0.5–0.6 mg once or twice daily | Gout flares, CPPD | Most effective when started within 12–24 hours of flare onset; GI side effects common at higher doses | | **Urate-lowering therapy** | Allopurinol 100–800 mg/day; Febuxostat 40–80 mg/day | Chronic gout with recurrent flares or tophi | Target serum urate < 6 mg/dL; allopurinol requires dose titration; hypersensitivity screening (HLA-B*5801) recommended in certain populations | | **Duloxetine** | Cymbalta 60 mg/day | Chronic OA pain with or without concurrent depression | SNRI; FDA-approved for chronic musculoskeletal pain; may help centralized pain; prescriber monitors mood and hepatic function | | **Hyaluronic acid injections** | Synvisc, Euflexxa | Knee OA | Viscosupplementation; mixed evidence; conditionally not recommended by 2019 ACR guidelines for knee OA but may be considered when other therapies fail | **Who prescribes:** Primary care physicians manage most cases of uncomplicated OA, acute gout, and initial evaluation. Referral to a **rheumatologist** is appropriate for suspected autoimmune arthritis, unclear diagnosis, or need for DMARDs/biologics. **Orthopedic surgeons** are consulted for structural problems, advanced joint damage, or consideration of joint replacement. --- ## Lab Tests Typically Ordered The choice of laboratory investigations depends on the clinical presentation — acute vs. chronic, monoarticular vs. polyarticular, and the presence of systemic features. | Test | Rationale | |---|---| | **Complete blood count (CBC)** | Evaluate for infection (elevated WBC), anemia of chronic disease (RA, SLE), or thrombocytopenia (SLE) — [more info](/tests/complete-blood-count) | | **Erythrocyte sedimentation rate (ESR)** | Non-specific marker of inflammation; elevated in RA, infection, and other inflammatory conditions — [more info](/tests/erythrocyte-sedimentation-rate) | | **C-reactive protein (CRP)** | Acute-phase reactant; more responsive than ESR to acute changes; useful for monitoring disease activity — [more info](/tests/c-reactive-protein) | | **Rheumatoid factor (RF)** | Present in ~70–80 % of RA patients; not specific (positive in infections, other autoimmune conditions, and some healthy elderly individuals) — [more info](/tests/rheumatoid-factor) | | **Anti-cyclic citrullinated peptide (anti-CCP)** | More specific than RF for RA (~95 % specificity); presence may predict more aggressive disease — [more info](/tests/anti-ccp-antibodies) | | **Antinuclear antibody (ANA)** | Screening test for SLE and other connective tissue diseases; sensitive but not specific — [more info](/tests/antinuclear-antibody) | | **Serum uric acid** | Elevated in gout (though may be normal during an acute flare); guides urate-lowering therapy — [more info](/tests/uric-acid) | | **Synovial fluid analysis** | Gold standard for diagnosing septic arthritis (cell count, Gram stain, culture) and crystal arthropathies (polarized light microscopy for urate or CPPD crystals) — [more info](/tests/synovial-fluid-analysis) | | **HLA-B27** | Associated with ankylosing spondylitis, reactive arthritis, and psoriatic arthritis; supports clinical diagnosis — [more info](/tests/hla-b27) | | **Lyme serology (ELISA + Western blot)** | In endemic areas, for monoarticular or oligoarticular arthritis with potential tick exposure — [more info](/tests/lyme-disease-test) | | **Basic metabolic panel and hepatic panel** | Baseline before starting NSAIDs (renal function) or DMARDs such as methotrexate (hepatic function) — [more info](/tests/basic-metabolic-panel) | | **X-ray of affected joint** | Assess joint space narrowing, osteophytes (OA), erosions (RA), chondrocalcinosis (CPPD), or fractures | | **MRI** | Superior soft-tissue detail for meniscal tears, ligament injuries, early erosive changes, or osteomyelitis | --- ## Special Populations ### Children and Adolescents Joint pain in children warrants careful evaluation, as the differential diagnosis differs significantly from adults. - **Juvenile idiopathic arthritis (JIA)** is the most common chronic rheumatic disease of childhood. Diagnosis requires arthritis persisting for ≥ 6 weeks in a child under 16 years, after exclusion of other causes. - **Growing pains** — typically bilateral lower-extremity pain occurring at night in children aged 3–12, with normal examination and labs — are a diagnosis of exclusion. - **Septic arthritis and osteomyelitis** are emergencies in children; a febrile child refusing to move a joint must be evaluated urgently. - **Pharmacological caution:** Aspirin is generally **contraindicated** in children under 16 due to the risk of Reye syndrome. Ibuprofen and naproxen may be used in children at weight-based doses, but dosing should always be confirmed with a pediatrician or pharmacist. Acetaminophen dosing in children is strictly weight-based (typically 10–15 mg/kg/dose every 4–6 hours; maximum 75 mg/kg/day, not exceeding adult dose). **Do not administer adult doses to children — always consult a pediatric dosing reference or healthcare provider.** ### Pregnancy Joint pain is common during pregnancy due to hormonal changes (relaxin), weight gain, and fluid retention. - **Acetaminophen** is generally considered the safest analgesic during pregnancy at standard doses. - **NSAIDs** should be **avoided in the third trimester** (risk of premature closure of the ductus arteriosus and oligohydramnios). The FDA issued a safety communication in 2020 warning against NSAID use after approximately 20 weeks of gestation due to the risk of low amniotic fluid. - **Methotrexate** is **absolutely contraindicated** in pregnancy (teratogenic; FDA category X). Women of childbearing potential on methotrexate must use effective contraception. - **Hydroxychloroquine** is generally considered safe in pregnancy and is continued in pregnant patients with SLE or RA to prevent flares. - **Biologic DMARDs** vary in pregnancy safety; decisions should be made jointly with a rheumatologist and obstetrician. Certolizumab has the most favorable data due to minimal placental transfer. - Non-pharmacological approaches (physical therapy, warm compresses, supportive garments) are first-line. ### Elderly (≥ 65 Years) Older adults are particularly vulnerable to medication-related adverse effects. - **Oral NSAIDs** carry heightened risks of GI bleeding, renal impairment, cardiovascular events, and drug interactions in this population. The American Geriatrics Society Beers Criteria recommend avoiding chronic NSAID use in older adults when possible. - **Topical NSAIDs** (e.g., diclofenac gel) are generally preferred over oral NSAIDs for localized OA in the elderly due to lower systemic absorption. - **Acetaminophen** remains appropriate at standard doses provided hepatic function is adequate, though the maximum daily dose may be reduced to 2000–3000 mg/day in frail elderly patients. - **Fall risk** must be considered when prescribing opioids, muscle relaxants, or sedating medications. - **Physical therapy** and exercise programs tailored to functional capacity are strongly recommended. - **Joint replacement surgery** (total knee or hip arthroplasty) is a highly effective option for severe OA that has failed conservative management; age alone is not a contraindication. ### Athletes Joint pain in athletes may arise from acute trauma, overuse, or inflammatory conditions. - **Acute injuries** (ligament tears, meniscal injuries, dislocations) may require surgical evaluation. - **Overuse injuries** (patellofemoral syndrome, iliotibial band syndrome) generally respond to activity modification, physical therapy, and biomechanical correction. - **Return to sport** after joint injury should be guided by objective criteria (strength, range of motion, functional testing), not time alone. - **NSAIDs** may impair tendon and bone healing if used chronically; short-term use for acute pain is generally acceptable. - **Corticosteroid injections** in athletes should be used cautiously, as they may weaken tendons and mask pain that serves a protective function. --- ## When to Escalate The urgency of seeking medical care depends on the clinical scenario. ### Emergency Department (Immediately) - Hot, swollen joint with fever — possible septic arthritis - Joint pain after significant trauma with deformity, inability to bear weight, or neurovascular compromise - Joint pain accompanied by signs of systemic illness (high fever, rigors, altered mental status, widespread rash) - Suspected joint dislocation ### Urgent Care or Same-Day GP Appointment - Acute, severely painful joint swelling (possible gout or pseudogout flare) - Joint pain with new skin rash, eye redness, or urethral discharge (possible reactive arthritis) - Rapidly worsening joint swelling over days without clear cause - Joint pain with significant functional limitation preventing work or daily activities ### Routine GP Appointment (Within 1–2 Weeks) - Joint pain persisting more than 2–4 weeks without improvement - Joint pain with morning stiffness lasting more than 30 minutes (suspect inflammatory arthritis) - Multiple joint involvement without clear mechanical cause - Joint pain with unintentional weight loss, persistent fatigue, or other systemic symptoms - Failure to respond to 2–4 weeks of OTC analgesics and self-care ### Referral to Rheumatologist - Suspected rheumatoid arthritis or other autoimmune arthritis - Positive autoimmune serologies (RF, anti-CCP, ANA) with clinical symptoms - Recurrent gout flares or tophaceous gout requiring long-term management - Need for DMARD or biologic therapy - Diagnostic uncertainty after initial workup ### Referral to Orthopedic Surgeon - Mechanical symptoms (locking, catching, giving way) suggesting internal derangement - Severe OA unresponsive to conservative management — consideration of joint replacement - Ligament or meniscal tears potentially requiring surgical repair - Post-traumatic joint instability --- > **Disclaimer:** This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized guidance regarding your symptoms and health conditions. --- ## References [1] Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. *Ann Rheum Dis*. 2014;73(7):1323-1330. PMID:24553908. [2] Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. *Arthritis Rheum*. 2010;62(9):2569-2581. PMID:20872595. [3] Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee: a Cochrane systematic review. *Cochrane Database Syst Rev*. 2015;1:CD004376. PMID:25461849. [4] da Costa BR, Reichenbach S, Keller N, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. *Lancet*. 2017;390(10090):e21-e33. PMID:28699595. [5] Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. *Arthritis Care Res (Hoboken)*. 2020;72(2):149-162. PMID:31908163. [6] Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. *Osteoarthritis Cartilage*. 2019;27(11):1578-1589. PMID:31278997. [7] Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. *Arthritis Rheumatol*. 2016;68(1):1-26. PMID:26545940. [8] U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later. October 2020. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later. [9] National Institute for Health and Care Excellence (NICE). Osteoarthritis: care and management. Clinical guideline [CG177]. Updated 2022. Available at: https://www.nice.org.uk/guidance/cg177.